Biogen (BIIB) PT Lowered to $255 at Baird
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Price: $210.65 +0.85%
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Baird analyst Brian Skorney lowered the price target on Biogen (NASDAQ: BIIB) to $255.00 (from $300.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Wolfe Research Upgrades Biogen (BIIB) to Outperform
- Hon Hai Precision Industry Co Ltd. (2317:TT) (HNHPD) PT Raised to NT$435 at Macquarie
- Applied Aerospace & Defense (AADX) PT Lowered to $23 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
